First Name *

Last Name *

Email Address *

Phone *

Company Name *

Country *

State * Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

Territory * Alberta British Columbia Manitoba New Brunswick Newfoundland Northwest Territories Nunavut Nova Scotia Ontario Prince Edward Island Quebec Saskatchewan Yukon

Peptide-Injectable FIH Reason for Contact * Clinical Phase 0 Peptide DevelopmentPeptide Drug Substance Clinical Supply for Phase IInjectable Formulation for Phase I-IIHelp with CMC Readiness for Clinical TrialCommercial scale-up for Peptide TherapeuticOther

Comments *

Per GDPR effective 5/25/18, do you agree to CordenPharma's Privacy Policy below and wish to be contacted via email for marketing purposes? * Yes No

Comments